GB1297719A - - Google Patents
Info
- Publication number
- GB1297719A GB1297719A GB1297719DA GB1297719A GB 1297719 A GB1297719 A GB 1297719A GB 1297719D A GB1297719D A GB 1297719DA GB 1297719 A GB1297719 A GB 1297719A
- Authority
- GB
- United Kingdom
- Prior art keywords
- composition
- copolymer
- methacrylate
- waterdispersible
- botfly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 abstract 4
- SOGAXMICEFXMKE-UHFFFAOYSA-N Butylmethacrylate Chemical compound CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 abstract 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract 2
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 abstract 1
- VNRJVVUVDYYTRO-UHFFFAOYSA-N 2-(trimethylazaniumyl)ethoxymethanedithioate Chemical compound C[N+](C)(C)CCOC([S-])=S VNRJVVUVDYYTRO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005995 Aluminium silicate Substances 0.000 abstract 1
- 229920002261 Corn starch Polymers 0.000 abstract 1
- 241000283073 Equus caballus Species 0.000 abstract 1
- 206010061217 Infestation Diseases 0.000 abstract 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 abstract 1
- 240000004658 Medicago sativa Species 0.000 abstract 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 abstract 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 abstract 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- 229920000881 Modified starch Polymers 0.000 abstract 1
- 241000257191 Oestridae Species 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 229920001213 Polysorbate 20 Polymers 0.000 abstract 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 1
- 239000004141 Sodium laurylsulphate Substances 0.000 abstract 1
- 235000012211 aluminium silicate Nutrition 0.000 abstract 1
- PZZYQPZGQPZBDN-UHFFFAOYSA-N aluminium silicate Chemical compound O=[Al]O[Si](=O)O[Al]=O PZZYQPZGQPZBDN-UHFFFAOYSA-N 0.000 abstract 1
- 229910000323 aluminium silicate Inorganic materials 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- HWDGVJUIHRPKFR-ZWPRWVNUSA-I copper;trisodium;3-[(2s,3s)-20-(carboxylatomethyl)-18-(dioxidomethylidene)-8-ethenyl-13-ethyl-3,7,12,17-tetramethyl-2,3-dihydroporphyrin-23-id-2-yl]propanoate Chemical compound [Na+].[Na+].[Na+].[Cu+2].C1=C([N-]2)C(CC)=C(C)C2=CC(C(=C2C)C=C)=NC2=CC([C@H]([C@@H]2CCC([O-])=O)C)=NC2=C(CC([O-])=O)C2=NC1=C(C)C2=C([O-])[O-] HWDGVJUIHRPKFR-ZWPRWVNUSA-I 0.000 abstract 1
- 239000008120 corn starch Substances 0.000 abstract 1
- 239000003623 enhancer Substances 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- -1 flavouring Substances 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000011777 magnesium Substances 0.000 abstract 1
- 229910052749 magnesium Inorganic materials 0.000 abstract 1
- 235000019359 magnesium stearate Nutrition 0.000 abstract 1
- 235000012054 meals Nutrition 0.000 abstract 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 235000013379 molasses Nutrition 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 abstract 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 abstract 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 abstract 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 abstract 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
- 239000000454 talc Substances 0.000 abstract 1
- 229910052623 talc Inorganic materials 0.000 abstract 1
- 235000012222 talc Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4558070A | 1970-06-11 | 1970-06-11 | |
| NL7113971A NL7113971A (en) | 1971-10-12 | 1971-10-12 | Anti botfly larvae compsn - contg choline xanthate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1297719A true GB1297719A (enExample) | 1972-11-29 |
Family
ID=26644688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1297719D Expired GB1297719A (enExample) | 1970-06-11 | 1971-10-11 |
Country Status (4)
| Country | Link |
|---|---|
| BE (1) | BE774408A (enExample) |
| DE (1) | DE2150539A1 (enExample) |
| FR (1) | FR2158076B1 (enExample) |
| GB (1) | GB1297719A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0040590A3 (en) * | 1980-05-21 | 1983-01-12 | Aktiebolaget Hässle | A pharmaceutical preparation having improved release properties |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2972613A (en) * | 1959-03-09 | 1961-02-21 | Dawe S Lab Inc | Cyclic choline xanthate |
-
1971
- 1971-10-11 DE DE19712150539 patent/DE2150539A1/de active Pending
- 1971-10-11 GB GB1297719D patent/GB1297719A/en not_active Expired
- 1971-10-25 BE BE774408A patent/BE774408A/xx unknown
- 1971-10-26 FR FR7138478A patent/FR2158076B1/fr not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0040590A3 (en) * | 1980-05-21 | 1983-01-12 | Aktiebolaget Hässle | A pharmaceutical preparation having improved release properties |
Also Published As
| Publication number | Publication date |
|---|---|
| BE774408A (fr) | 1972-02-14 |
| DE2150539A1 (de) | 1973-04-19 |
| FR2158076B1 (enExample) | 1975-02-07 |
| FR2158076A1 (enExample) | 1973-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0420888B2 (enExample) | ||
| KR920009404A (ko) | 위 체류 시간 지연성 제산제 | |
| DE3266332D1 (en) | Sustained release pharmaceutical composition | |
| KR840000229A (ko) | 디피리다몰의 경구용 제형의 제조방법 | |
| ATE219931T1 (de) | Darmlösliche grannulatkörner enthaltende tablette | |
| ATE62130T1 (de) | Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe. | |
| JPH10127258A5 (enExample) | ||
| US4066754A (en) | Slow release bolus | |
| NZ218734A (en) | Tablets containing coated microspheres which contain ibuprofen (2-(4-isobutyl phenyl)propanoic acid) | |
| IE36335B1 (en) | Layered bolus for animal husbandry providing for immediate and sustained release of medicament | |
| US3119738A (en) | Medication for ruminants | |
| JPH0813736B2 (ja) | 単斜結晶構造を有する熱―、光―、及び湿気―感受性活性成分を含む錠剤又は糖剤組成物の調製方法 | |
| GB1297719A (enExample) | ||
| JPS6320409B2 (enExample) | ||
| US3608064A (en) | Milk-buffered aspirin | |
| ES531346A0 (es) | Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph | |
| Katual et al. | Formulation, optimization and in-vitro evaluation of metronidazole 500mg floating tablets for the treatment of helicobacter pylori induced gastric inflammatory disorder | |
| IE35419L (en) | Pharmaceutical composition containing cyclobenzaprine | |
| US3740432A (en) | Vitamin complexes of niacinamide,riboflavin and sodium ascorbate | |
| GB1293329A (en) | Pharmaceutical compositions | |
| US3155576A (en) | Ulcer therapy composition and method of using same | |
| US3709989A (en) | Composition and method for treatment of ossilets and pathological calcification in animals | |
| US3754082A (en) | Process and composition for botfly larvae eliminination | |
| IE33949L (en) | Therapeutic composition | |
| US2678296A (en) | Nu-benzyl-betachloropropionamide anticonvulsant article of manufacture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |